Abstract
Hematopoietic SCT is now an established treatment modality with definitive indications for many hematological disorders. However, this line of treatment requires tremendous resources, and it becomes increasingly difficult for transplanters practicing in the developing world to reconcile the difference between what is possible and what is available. On the basis of 18 years of experience and more than 1300 transplants, this article will focus on special issues, which we think are important for hematopoietic SCT practices in developing countries, taking the program in Egypt as an example that may be applicable to other countries in the developing world. The SCT program in Egypt started in 1989 on a narrow scale. In 1997, the transplant rate increased dramatically with the opening of the SCT unit at the Nasser Institute. Our team is registered in the Center for International Blood and Marrow Transplant Research. The total number of transplants performed till June 2007 is 1362; 80% of the cases are allogeneic and 20% autologous. There are seven other centers in Egypt performing mainly autologous transplants.
References
Aug 1, 1982·American Journal of Hematology·S C Wong, M A Ali
May 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H M ShulmanG B McDonald
Jul 21, 1998·Annals of the New York Academy of Sciences·C Politis
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S I StrasserG B McDonald
Jul 8, 1999·The New England Journal of Medicine·N F Olivieri
Sep 1, 1999·Bone Marrow Transplantation·H MahmoudD El-Kadi
Dec 10, 1999·Transplantation·A LocasciulliA Alberti
Feb 7, 2001·Lancet·C FrankI Sallam
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F Abdel-AzizI Sallam
Dec 22, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M HabibI Sallam
Nov 30, 2004·Bone Marrow Transplantation·A M KamelD Sayed
Dec 25, 2004·European Journal of Gastroenterology & Hepatology·Manal H El-SayedHossam K Mahmoud
Citations
Mar 17, 2011·Annals of Hematology·Lalit KumarRoopa Hariprasad
Dec 2, 2008·Bone Marrow Transplantation·M D AljurfA Gratwohl
Jan 23, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rajat KumarWael Saber
Jan 30, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Mahmoud AljurfHassan El Solh
Aug 31, 2012·Pediatric Transplantation·M Akif YesilipekVolkan Hazar
Dec 2, 2011·Annals of the New York Academy of Sciences·Mohamed-Ridha BarboucheAhmed Aziz Bousfiha
Feb 18, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Monica M MatsumotoKirstin R W Matthews
Mar 29, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Syed O A AhmedMahmoud Aljurf
Jul 6, 2011·Hematology/oncology and Stem Cell Therapy·Said Yousef Ahmed MohamedArdeshir Ghavamzadeh
Apr 8, 2016·Blood·Matthew C Canver, Stuart H Orkin
Sep 13, 2016·Bone Marrow Transplantation·A A HusseinUNKNOWN Pediatric Cancer Working Committee of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group
Aug 15, 2009·Current Opinion in Hematology·Alois Gratwohl, Helen Baldomero
Sep 7, 2017·Current Opinion in Hematology·Rajat KumarBiju George
Sep 23, 2018·Journal of Global Oncology·Mahmoud M ElzembelyAlaa El-Haddad
Sep 23, 2018·Journal of Global Oncology·Albert C YehBimalangshu R Dey